CYPB - Cypress BioScience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: muddphudd who wrote (229)	5/20/1998 12:58:00 AM
From: Jay Lowe	Read Replies (3) of 586

Repeat of msg 133 ... burnrate. CYPB Highlights - 1Q results (.05) ... Gruss Report expected (.08) - company has $7.4M short term cash available - current burn rate $2.5M - Prosorba Column device now being used for ITP - Phase III trial of Prosorba for RA ended early - CYPB to file PMA for RA indication of Prosorba mid-98 - Cyplex(tm) infusible platelet alternative Phase II trial in process - Gruss report sets 2 month price target @ $6.75 last quarterly report approx msg 133

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next